716 - A preclinical evaluation of niraparib efficacy as monotherapy, maintenance and after olaparib treatment (PARP inhibitor after PARP inhibitor) in patient-derived ovarian xenograft tumor models
| Autor: | Mikule, K., Wang, S., Weroha, S.J., Nakashima, J., Wilcoxen, K. |
|---|---|
| Zdroj: | In European Journal of Cancer February 2017 72 Supplement 1:S96-S96 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect